4Basebio Ag Reports Earnings Results for the Full Year Ended December 31, 2019
April 24, 2020 at 01:30 am EDT
4basebio AG announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was EUR 1.052 million compared to EUR 1.174 million a year ago. Net loss was EUR 2.653 million compared to EUR 301,000 a year ago. Basic loss per share from continuing operations was EUR 0.07 compared to EUR 0.06 a year ago. Basic loss per share was EUR 0.05 compared to EUR 0.01 a year ago. Diluted loss per share from continuing operations was EUR 0.06 compared to EUR 0.05 a year ago. Diluted loss per share was EUR 0.04 compared to EUR 0.01 a year ago.